British Journal of Cancer - Table of Contents alert Volume 119 Issue 8

Advertisement Researchoncology.com Explore the latest science, research, and clinical trials in hematology and oncology. TABLE OF CONTENTS Volume 119, Issue 8 In this issue Editorial Article Brief Communication Article Brief Communication Also new AOP Editorial Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma Chung-Han Lee & Robert Motzer British Journal of Cancer 2018 119 :911 - 912; October 17, 2018; 10.1038/s41416-018-0175-x Abstract | Full Text Moving the needle on colorectal cancer genetics: it takes more than two to TANGO Luis G. Carvajal-Carmona British Journal of Cancer 2018 119 :913 - 914; October 04, 2018; 10.1038/s41416-018-0219-2 Abstract | Full Text Article D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis Luis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, Maria Isabel Asensio-Cruz, Isabel Blasco-Esquivias et al. British Journal of Cancer 2018 119 :915 - 921; October 15, 2018; 10.1038/s41416-018-0269-5 Abstract | Full Text Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre Brent O’Carrigan, Joline Si Jing Lim, Awais Jalil, Samuel John Harris, Dionysis Papadatos-Pastos et al. British Journal of Cancer 2018 119 :922 - 927; October 15, 2018; 10.1038/s41416-018-0290-8 Abstract | Full Text Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis David E. Gerber, M. Shaalan Beg, Farjana Fattah, Arthur E. Frankel, Oluwatomilade Fatunde et al. British Journal of Cancer 2018 119 :928 - 936; October 15, 2018; 10.1038/s41416-018-0278-4 Abstract | Full Text Brief Communication Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines? Sarah Watson, Jessica Menis, Capucine Baldini, Patricia Martin-Romano, Jean-Marie Michot et al. British Journal of Cancer 2018 119 :937 - 939; October 17, 2018; 10.1038/s41416-018-0245-0 Abstract | Full Text Article An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer Rubén A. Bartolomé, Marta Jaén & J. Ignacio Casal British Journal of Cancer 2018 119 :940 - 949; October 15, 2018; 10.1038/s41416-018-0259-7 Abstract | Full Text Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy Jean-David Fumet, Corentin Richard, Fanny Ledys, Quentin Klopfenstein, Philippe Joubert et al. British Journal of Cancer 2018 119 :950 - 960; October 15, 2018; 10.1038/s41416-018-0220-9 Abstract | Full Text CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer Akira Ooki, Christopher J. VandenBussche, Max Kates, Noah M. Hahn, Andres Matoso et al. British Journal of Cancer 2018 119 :961 - 970; October 17, 2018; 10.1038/s41416-018-0291-7 Abstract | Full Text Colon-specific eQTL analysis to inform on functional SNPs Victor Moreno, M. Henar Alonso, Adrià Closa, Xavier Vallés, Anna Diez-Villanueva et al. British Journal of Cancer 2018 119 :971 - 977; October 04, 2018; 10.1038/s41416-018-0018-9 Abstract | Full Text Primary constitutional MLH1 epimutations: a focal epigenetic event Estela Dámaso, Adela Castillejo, María del Mar Arias, Julia Canet-Hermida, Matilde Navarro et al. British Journal of Cancer 2018 119 :978 - 987; October 04, 2018; 10.1038/s41416-018-0019-8 Abstract | Full Text Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome Evropi Theodoratou, Susan M Farrington, Maria Timofeeva, Farhat VN Din, Victoria Svinti et al. British Journal of Cancer 2018 119 :988 - 993; August 21, 2018; 10.1038/s41416-018-0117-7 Abstract | Full Text Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells Marco Cordani, Giovanna Butera, Ilaria Dando, Margalida Torrens-Mas, Elena Butturini et al. British Journal of Cancer 2018 119 :994 - 1008; October 15, 2018; 10.1038/s41416-018-0288-2 Abstract | Full Text Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma Elitsa A. Ananieva, Joshua N. Bostic, Ashley A. Torres, Hannah R. Glanz, Sean M. McNitt et al. British Journal of Cancer 2018 119 :1009 - 1017; October 15, 2018; 10.1038/s41416-018-0283-7 Abstract | Full Text Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults Kyu Rae Lee, Mi Hae Seo, Kyung Do Han, Jinhyung Jung & In Cheol Hwang British Journal of Cancer 2018 119 :1018 - 1027; October 17, 2018; 10.1038/s41416-018-0214-7 Abstract | Full Text Maternal exposure to gasoline and exhaust increases the risk of childhood leukaemia in offspring – a prospective study in the Norwegian Mother and Child Cohort Study Jorunn Kirkeleit, Trond Riise, Tone Bjørge, David C. Christiani, Magne Bråtveit et al. British Journal of Cancer 2018 119 :1028 - 1035; October 15, 2018; 10.1038/s41416-018-0295-3 Abstract | Full Text Brief Communication The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study Todd Smith, Marc J. Gunter, Ioanna Tzoulaki & David C. Muller British Journal of Cancer 2018 119 :1036 - 1039; October 16, 2018; 10.1038/s41416-018-0282-8 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.